These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 23090423

  • 1. Psoriasis triggered by infliximab in a patient with Behçet's disease.
    Kawazoe Y, Sugita S, Yamada Y, Akino A, Miura K, Mochizuki M.
    Jpn J Ophthalmol; 2013 Jan; 57(1):95-7. PubMed ID: 23090423
    [Abstract] [Full Text] [Related]

  • 2. Psoriasis induced by anti-tumor necrosis factor therapy: a paradoxical adverse reaction.
    Sfikakis PP, Iliopoulos A, Elezoglou A, Kittas C, Stratigos A.
    Arthritis Rheum; 2005 Aug; 52(8):2513-8. PubMed ID: 16052599
    [Abstract] [Full Text] [Related]

  • 3. Infliximab treatment for ocular and extraocular manifestations of Behçet's disease.
    Accorinti M, Pirraglia MP, Paroli MP, Priori R, Conti F, Pivetti-Pezzi P.
    Jpn J Ophthalmol; 2007 Aug; 51(3):191-6. PubMed ID: 17554481
    [Abstract] [Full Text] [Related]

  • 4. The effect of anti-tumour necrosis factor alpha (infliximab) on sight-threatening uveitis in a patient with Behçet's disease.
    Morris DS, Gavin MP, Sturrock RD.
    Adv Exp Med Biol; 2003 Aug; 528():557-9. PubMed ID: 12918763
    [No Abstract] [Full Text] [Related]

  • 5. Real-world efficacy of adalimumab and infliximab for refractory intestinal Behçet's disease.
    Sugimura N, Mizoshita T, Sugiyama T, Togawa S, Miyaki T, Suzuki T, Tanida S, Kataoka H, Sasaki M.
    Dig Liver Dis; 2019 Jul; 51(7):967-971. PubMed ID: 30872086
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Case of neuro-Behçet's disease successfully maintained a remission using infliximab for 2 years.
    Kanemaru H, Makino T, Jinnin M, Yonemitsu A, Makino K, Ihn H.
    J Dermatol; 2013 Aug; 40(8):632-4. PubMed ID: 23724912
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Anti-TNF-α therapy in patients with refractory uveitis due to Behçet's disease: a 1-year follow-up study of 124 patients.
    Calvo-Río V, Blanco R, Beltrán E, Sánchez-Bursón J, Mesquida M, Adán A, Hernandez MV, Hernandez Garfella M, Valls Pascual E, Martínez-Costa L, Sellas-Fernández A, Cordero Coma M, Díaz-Llopis M, Gallego R, Salom D, García Serrano JL, Ortego N, Herreras JM, Fonollosa A, García-Aparicio AM, Maíz O, Blanco A, Torre I, Fernández-Espartero C, Jovani V, Peiteado-Lopez D, Pato E, Cruz J, Fernández-Cid C, Aurrecoechea E, García M, Caracuel MA, Montilla C, Atanes A, Hernandez FF, Insua S, González-Suárez S, Sánchez-Andrade A, Gamero F, Linares L, Romero-Bueno F, García AJ, Almodovar R, Minguez E, Carrasco Cubero C, Olive A, Vázquez J, Ruiz Moreno O, Jiménez-Zorzo F, Manero J, Muñoz Fernández S, Rueda-Gotor J, González-Gay MA.
    Rheumatology (Oxford); 2014 Dec; 53(12):2223-31. PubMed ID: 24996907
    [Abstract] [Full Text] [Related]

  • 10. Infliximab-induced psoriasis during therapy for Crohn's disease.
    Steinwurz F, Denadai R, Saad-Hossne R, Queiroz ML, Teixeira FV, Romiti R.
    J Crohns Colitis; 2012 Jun; 6(5):610-6. PubMed ID: 22398095
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of the long-term efficacy and safety of infliximab treatment for uveitis in Behçet's disease: a multicenter study.
    Takeuchi M, Kezuka T, Sugita S, Keino H, Namba K, Kaburaki T, Maruyama K, Nakai K, Hijioka K, Shibuya E, Komae K, Hori J, Ohguro N, Sonoda KH, Mizuki N, Okada AA, Ishibashi T, Goto H, Mochizuki M.
    Ophthalmology; 2014 Oct; 121(10):1877-84. PubMed ID: 24950593
    [Abstract] [Full Text] [Related]

  • 12. Behçet's ileocolitis: successful treatment with tumor necrosis factor-alpha antibody (infliximab) therapy: report of a case.
    Kram MT, May LD, Goodman S, Molinas S.
    Dis Colon Rectum; 2003 Jan; 46(1):118-21. PubMed ID: 12544532
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Efficacy of TNF-alpha antagonist and other immunomodulators in the treatment of patients with ophthalmologic manifestations of Behcet's disease and HLA B51 positive vasculitis].
    Zlatanović G, Jovanović S, Veselinović D, Zivković M.
    Vojnosanit Pregl; 2012 Feb; 69(2):168-74. PubMed ID: 22500372
    [Abstract] [Full Text] [Related]

  • 16. Infliximab for the treatment of resistant oral ulcers in Behçet's disease: a case report and review of the literature.
    Almoznino G, Ben-Chetrit E.
    Clin Exp Rheumatol; 2007 Feb; 25(4 Suppl 45):S99-102. PubMed ID: 17949561
    [Abstract] [Full Text] [Related]

  • 17. Combination therapy of infliximab and thalidomide for refractory entero-Behcet's disease: a case report.
    Li Y, Han Z, Wang X, Mo Z, Zhang W, Li A, Liu S.
    BMC Gastroenterol; 2013 Dec 09; 13():167. PubMed ID: 24321021
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behçet's disease.
    Sugita S, Kawazoe Y, Imai A, Yamada Y, Horie S, Mochizuki M.
    Arthritis Res Ther; 2012 May 01; 14(3):R99. PubMed ID: 22546542
    [Abstract] [Full Text] [Related]

  • 19. Clinical course of patients with Behçet's uveitis following discontinuation of infliximab therapy.
    Kawaguchi T, Kawazoe Y, Kamoi K, Miyanaga M, Takase H, Sugita S, Mochizuki M.
    Jpn J Ophthalmol; 2014 Jan 01; 58(1):75-80. PubMed ID: 24129677
    [Abstract] [Full Text] [Related]

  • 20. Mimicry between intestinal Behçet's disease and inflammatory bowel disease.
    Rodrigues-Pinto E, Magro F, Pimenta S, Guimarães J, Macedo G.
    J Crohns Colitis; 2014 Jul 01; 8(7):714-5. PubMed ID: 24389388
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.